Skip to main content
. 2016 Jan 19;11(1):e0146948. doi: 10.1371/journal.pone.0146948

Table 2. Correlations between mitochondrial tumor suppressor genes (SIRT3, SIRT4, MTUS1), mitochondrial DNA repair gene (OGG1-2a), proliferation marker (Ki-67) expression and clinicopathological characteristics of primary HNSCC.

T stage C stage N stage M stage Grade Survival SIRT3 SIRT4 MTUS1 OGG1-2a Ki-67
T stage 0.665*** 0.501*** 0.078 0.222* -0.006 0.11 -0.074 0.127 0.005 0.059
C stage 0.387*** 0.053 0.204* 0.021 0.138 -0.1 0.085 0.048 0.053
N stage 0.380*** 0.037 -0.051 -0.226** -0.261*** -0.214* -0.378*** 0.078
M stage. 0.125 0.01 -0.30*** -0.185* -0.289*** -0.216* 0.24**
Grade 0.154 0.007 -0.15 0.105 0.012 0.094
Survival 0.15 0.05 0.08 -0.083 0.100
SIRT3 0.523*** 0.273*** 0.213* -0.054
SIRT4 0.08 0.338*** -0.108
MTUS1 0.125* -0.674***
OGG1-2a 0.224*
Ki-67

Spearman Correlation Coefficients. The expression levels of SIRT3, SIRT4, MTUS1, OGG1-2a and Ki-67 for Patient Cohort were based on the relative mRNA level.

* p < 0.05

** p < 0.01 and

*** p < 0.001. The p values were computed using one way ANOVA and χ2-test.